These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12353075)

  • 1. Expression and characterization of recombinant murine factor VIII.
    Doering C; Parker ET; Healey JF; Craddock HN; Barrow RT; Lollar P
    Thromb Haemost; 2002 Sep; 88(3):450-8. PubMed ID: 12353075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and characterization of recombinant ovine coagulation factor VIII.
    Zakas PM; Gangadharan B; Almeida-Porada G; Porada CD; Spencer HT; Doering CB
    PLoS One; 2012; 7(11):e49481. PubMed ID: 23152911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of thrombin generation in hemophilia A plasma by coagulation factor VIII and characterization of antibody-specific inhibition.
    Doshi BS; Gangadharan B; Doering CB; Meeks SL
    PLoS One; 2012; 7(10):e48172. PubMed ID: 23144741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of human factor VIII inhibitors in rats by immunization with human recombinant factor VIII: a small animal model for humans with high responder inhibitor phenotype.
    Jarvis MA; Levin LG; Harrison JA; DePianto DJ; Suzuki CM; Ziaja CL; Brown JE; Jolly KW; Reisner HM; Abildgaard CF; Powell JS
    Thromb Haemost; 1996 Feb; 75(2):318-25. PubMed ID: 8815584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance.
    Reipert BM; Sasgary M; Ahmad RU; Auer W; Turecek PL; Schwarz HP
    Thromb Haemost; 2001 Dec; 86(6):1345-52. PubMed ID: 11776297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of coagulation-associated processes on factor VIII immunogenicity in a mouse model of severe hemophilia A.
    Gangadharan B; Delignat S; Ollivier V; Gupta N; Mackman N; Kaveri SV; Lacroix-Desmazes S
    J Thromb Haemost; 2014 Dec; 12(12):2065-9. PubMed ID: 25267332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical, immunological, and in vivo functional characterization of B-domain-deleted factor VIII.
    Pittman DD; Alderman EM; Tomkinson KN; Wang JH; Giles AR; Kaufman RJ
    Blood; 1993 Jun; 81(11):2925-35. PubMed ID: 8499631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of immune tolerance by neonatal intravenous injection of human factor VIII in murine hemophilia A.
    Madoiwa S; Yamauchi T; Hakamata Y; Kobayashi E; Arai M; Sugo T; Mimuro J; Sakata Y
    J Thromb Haemost; 2004 May; 2(5):754-62. PubMed ID: 15099282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated factor VIII gene expression results in attenuated anti-factor VIII-specific immunity in hemophilia A mice compared with factor VIII protein infusion.
    Bristol JA; Gallo-Penn A; Andrews J; Idamakanti N; Kaleko M; Connelly S
    Hum Gene Ther; 2001 Sep; 12(13):1651-61. PubMed ID: 11535168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term induction of immune tolerance after blockade of CD40-CD40L interaction in a mouse model of hemophilia A.
    Rossi G; Sarkar J; Scandella D
    Blood; 2001 May; 97(9):2750-7. PubMed ID: 11313267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic stem cells encoding porcine factor VIII induce pro-coagulant activity in hemophilia A mice with pre-existing factor VIII immunity.
    Doering CB; Gangadharan B; Dukart HZ; Spencer HT
    Mol Ther; 2007 Jun; 15(6):1093-9. PubMed ID: 17387335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of factor VIII-specific unresponsiveness by intrathymic factor VIII injection in murine hemophilia A.
    Madoiwa S; Yamauchi T; Kobayashi E; Hakamata Y; Dokai M; Makino N; Kashiwakura Y; Ishiwata A; Ohmori T; Mimuro J; Sakata Y
    J Thromb Haemost; 2009 May; 7(5):811-24. PubMed ID: 19220731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of antibodies induced by human factor VIII in a murine knockout model of hemophilia A.
    Reipert BM; Ahmad RU; Turecek PL; Schwarz HP
    Thromb Haemost; 2000 Nov; 84(5):826-32. PubMed ID: 11127864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of the antigenicity of factor VIII toward complex inhibitory antibody plasmas using multiply-substituted hybrid human/porcine factor VIII molecules.
    Barrow RT; Healey JF; Gailani D; Scandella D; Lollar P
    Blood; 2000 Jan; 95(2):564-8. PubMed ID: 10627463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for the decreased procoagulant activity of human factor VIII compared to the porcine homolog.
    Lollar P; Parker ET
    J Biol Chem; 1991 Jul; 266(19):12481-6. PubMed ID: 1905722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A major determinant of the immunogenicity of factor VIII in a murine model is independent of its procoagulant function.
    Meeks SL; Cox CL; Healey JF; Parker ET; Doshi BS; Gangadharan B; Barrow RT; Lollar P
    Blood; 2012 Sep; 120(12):2512-20. PubMed ID: 22855607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor VIII associated with lipidic nanoparticles retains efficacy in the presence of anti-factor VIII antibodies in hemophilia A mice.
    Shetty KA; Kosloski MP; Mager DE; Balu-Iyer SV
    Biopharm Drug Dispos; 2016 Oct; 37(7):409-420. PubMed ID: 27418232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Biophysical Properties of Phosphatidylserine Particle on Immune Tolerance Induction Toward Factor VIII in a Hemophilia A Mouse Model.
    Ramakrishnan R; Balu-Iyer SV
    J Pharm Sci; 2016 Oct; 105(10):3039-3045. PubMed ID: 27431011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insect cell-based expression and characterization of a single-chain variable antibody fragment directed against blood coagulation factor VIII.
    Kurasawa JH; Shestopal SA; Jha NK; Ovanesov MV; Lee TK; Sarafanov AG
    Protein Expr Purif; 2013 Apr; 88(2):201-6. PubMed ID: 23306063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy.
    Kubisz P; Plamenová I; Hollý P; Stasko J
    Med Sci Monit; 2009 Jun; 15(6):CS105-11. PubMed ID: 19488019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.